SCHEMBL2534334

SCHEMBL2534334

COC(=O)c1cc(Cl)cc2c1CC(C)(C)C(c1cccc(Br)c1)N2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
POLB P06746 3/20 0.38
SLC6A3 Q01959 2/20 0.36
LMNA P02545 1/20 0.36
RECQL P46063 1/20 0.36
MAPT P10636 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
MAPK1 P28482 1/20 0.36
CXCR5 P32302 1/20 0.36
APLNR P35414 1/20 0.36
CCR6 P51684 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
NOTCH1 P46531 1/20 0.35
F2RL1 P55085 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2532540 0.89 TSHR (0.39) TSHRNPSR1POLBSLC6A3LMNA
SCHEMBL2533756 0.85 TSHR (0.39) TSHRNPSR1POLBSLC6A3LMNA
SCHEMBL2532205 0.83 TSHR (0.39) TSHRNPSR1POLBSLC6A3LMNA
SCHEMBL2531570 0.83 NPSR1 (0.39) TSHRNPSR1POLBSLC6A3LMNA
SCHEMBL2530894 0.81 TSHR (0.39) TSHRNPSR1POLBSLC6A3LMNA
SCHEMBL2532918 0.81 TSHR (0.39) TSHRNPSR1POLBSLC6A3LMNA
SCHEMBL2535474 0.81 TSHR (0.39) TSHRNPSR1POLBSLC6A3LMNA
SCHEMBL2532518 0.76 TSHR (0.39) TSHRNPSR1POLBSLC6A3LMNA
SCHEMBL15509938 0.75 MAPT (0.36) TSHRPOLBMAPTKMT2AKDM4E
SCHEMBL2534291 0.75 TSHR (0.39) TSHRNPSR1POLBSLC6A3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558449-B1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-05 EP disclosed
US-8586747-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2013-11-19 US disclosed
EP-2558449-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2013-02-20 EP disclosed
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES Hoffmann-La Roche Inc (US) 2013-01-24 US disclosed
US-8344137-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMAN-LA ROCHE INC. (US) 2013-01-01 US disclosed
WO-2011128251-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-10-20 WO disclosed
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HUA MEDICINE (KY) 2011-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 TSHR 1338/4885NPSR1 853/4885POLB 4481/4885
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 TSHR 1338/4885NPSR1 853/4885POLB 4481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.